Skip to Main Content

Paper Details

Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i>BRAF<sup>V600E</sup></i>-Mutated Anaplastic Thyroid Carcinoma.
Thyroid
120
2019
Author NameAffiliation
Jennifer R WangThe University of Texas MD Anderson Cancer Center
Charles LuThe University of Texas MD Anderson Cancer Center
Michelle D Williamsand The University of Texas MD Anderson Cancer Center
Stephen Y LaiThe University of Texas MD Anderson Cancer Center
Stephen Y LaiThe University of Texas MD Anderson Cancer Center
David I RosenthalThe University of Texas MD Anderson Cancer Center
Clifton D FullerThe University of Texas MD Anderson Cancer Center
  • 1 - 7

Datasets

Release 1.2